EANS-Adhoc: Intercell AG / Intercell starts a Phase I clinical trial for a new Streptococcus pneumoniae vaccine
ad-hoc disclosure transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is solely responsible for the content of this announcement. Research & Development 07.04.2009 » Initiation of a first-in-man Phase I clinical trial in healthy subjects » Study aims to obtain safety and ...